These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14586834)

  • 1. Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer.
    Zhu AX; Willett CG
    Semin Radiat Oncol; 2003 Oct; 13(4):454-68. PubMed ID: 14586834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined modality treatment for rectal cancer.
    Zhu AX; Willett CG
    Semin Oncol; 2005 Feb; 32(1):103-12. PubMed ID: 15726512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined-modality therapy for rectal cancer: future prospects.
    Czito BG; Willett CG; Bendell JC
    Clin Colorectal Cancer; 2007 Sep; 6(9):625-33. PubMed ID: 17945034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiation with novel agents for rectal cancer.
    McMullen KP; Blackstock AW
    Clin Colorectal Cancer; 2002 May; 2(1):24-30. PubMed ID: 12453333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in new chemotherapeutic drugs for preoperative chemoradiation of locally advanced rectal cancer].
    Xiao L; Gao Y; Liu M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):93-7. PubMed ID: 24519058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemoradiation for rectal cancer: is more better?
    Patel A; Puthillath A; Yang G; Fakih MG
    Oncology (Williston Park); 2008 Jun; 22(7):814-26; discussion 826, 828-31, 836. PubMed ID: 18619122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?
    Glynne-Jones R; Mawdsley S; Harrison M
    Acta Oncol; 2010 Apr; 49(3):278-86. PubMed ID: 20180626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy for colorectal cancer.
    Meyerhardt JA; Mayer RJ
    N Engl J Med; 2005 Feb; 352(5):476-87. PubMed ID: 15689586
    [No Abstract]   [Full Text] [Related]  

  • 9. [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].
    Suzuki S; Shigaki N; Yokoyama S; Yamashita H; Sugita H; Arima N
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1545-7. PubMed ID: 21918360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapies for advanced colorectal cancer.
    Aggarwal S; Chu E
    Oncology (Williston Park); 2005 Apr; 19(5):589-95. PubMed ID: 15945340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of new agents in the treatment of colorectal cancer.
    Folprecht G; Köhne CH
    Oncology; 2004; 66(1):1-17. PubMed ID: 15031593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in colon cancer chemotheapy: nursing implications.
    Vega-Stromberg T
    Home Healthc Nurse; 2005 Mar; 23(3):154-64; quiz 165-6. PubMed ID: 15764920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.
    Corvò R; Pastrone I; Scolaro T; Marcenaro M; Berretta L; Chiara S
    Tumori; 2003; 89(4):361-7. PubMed ID: 14606636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for localized rectal cancer.
    Deutsch E; Ezra P; Mangoni M; Ducreux M
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix105-13. PubMed ID: 17631562
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
    Nishigami K; Kawami H; Yamaguchi T; Yamaguchi K; Kato S
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1765-8. PubMed ID: 19838045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
    Folprecht G; Köhne CH
    Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving treatment of advanced colon cancer.
    Segal NH; Saltz LB
    Annu Rev Med; 2009; 60():207-19. PubMed ID: 19630571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
    Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on clinical data with regimens inhibiting angiogenesis and epidermal growth factor receptor for patients with newly diagnosed metastatic colorectal cancer.
    Cohen DJ; Hochster HS
    Clin Colorectal Cancer; 2007 Dec; 7 Suppl 1():S21-7. PubMed ID: 18361803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].
    Guo X; Liu TS; Yu YY; Zhou YH; Chen Y; Zhuang RY; Cui YH
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):604-7. PubMed ID: 24314219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.